D-0436-2015 Class II Terminated
FDA drug recall D-0436-2015 was initiated by Heritage Pharmaceuticals, Inc. on Mar 25, 2015 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. The recall status is terminated (terminated May 15, 2017). Affected quantity: 6,816 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 15, 2015
- Initiation Date
- Mar 25, 2015
- Termination Date
- May 15, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,816 Bottles
Product description
GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Distribution pattern
U.S. Nationwide including Puerto Rico.
Code information
Lot #:18020994, Expiry: October 2015; Lot #: 18021311, Expiry: November 2015.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0436-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026